Market Overview:
The global bone morphogenetic proteins (BMPs) market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing number of spinal fusion surgeries, rising prevalence of trauma, and growing demand for reconstructive surgery. Additionally, the increasing awareness about oral-maxillofacial surgeries is also propelling the growth of this market. However, stringent regulatory requirements and high cost associated with BMPs are restraining the growth of this market. On the basis of type, rhBMP-2 dominates the global BMPs market and is expected to maintain its dominance during the forecast period. This can be attributed to its ability to promote bone healing and regeneration process in various applications such as spinal fusion surgery, trauma surgery, reconstructive surgery etc., thereby driving its demand globally.
Product Definition:
Bone Morphogenetic Proteins are proteins that play a role in the development of bones and teeth. They help to determine the shape and size of bones, as well as their ability to heal after being broken.
rhBMP-2:
rhBMP-2 (Regenerative Bone Morphogenetic Protein 2) is a protein that promotes bone regeneration. It is produced naturally by the body and can also be administered through injections. rhBMP-2 has been studied extensively in clinical trials as it shows efficacy similar to that of BMPs (bone morphogenetic proteins), which are commonly used for bone repair, but with fewer side effects.
rhBMP-7:
rhBMP-7 (Regenerative Bone Morphogenetic Protein 7) is a type of bone morphogenetic protein that promotes the growth of new bone tissue. It is naturally produced by the body and can also be obtained from sources like eggshells, bovine bones, and fish oil. rhBMP-7 has been studied in clinical trials for over a decade as an alternative therapy for osteoarthritis.
Application Insights:
The spinal fusion segment dominated the global market in 2017 and is projected to witness significant growth over the forecast period. The growing geriatric population, coupled with rising cases of trauma and road accidents worldwide, is expected to drive demand for bone morphogenetic proteins in spinal fusion surgeries. In addition, favorable reimbursement policies are likely to boost industry growth over the coming years.
Oral-maxillofacial surgery segment also held a considerable share in 2017 owing to high product penetration for treating dental disorders such as tooth decay and gum disease. Moreover, rhBMP-2 has been used successfully for facial reconstruction after cleft lip & palate repair procedures as well as nasal Reconstruction Surgery (NRS). These factors are anticipated to contribute towards revenue expansion during the forecast period.
Regional Analysis:
North America dominated the global bone morphogenetic proteins market in 2017. The presence of a large number of industry players and high adoption rate for advanced technologies are some factors contributing to the growth of this regional market. In addition, increasing demand for minimally invasive surgeries is also expected to drive growth over the forecast period.
Europe is anticipated to be one of the fastest-growing regions during the forecast period owing to its well-developed healthcare sector and increasing healthcare expenditure in various countries such as Germany, U.K., France, Italy, Spain among others.
Growth Factors:
- Increasing demand for bone grafts and implants due to rising incidence of bone fractures and other orthopedic disorders.
- Growing awareness about the benefits of Bone Morphogenetic Proteins in regenerative medicine.
- Rising investment in research and development activities for the development of novel Bone Morphogenetic Proteins products.
- Technological advancements in the field of regenerative medicine that are facilitating the use of Bone Morphogenetic Proteins products for tissue engineering applications.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bone Morphogenetic Proteins Market Research Report
By Type
rhBMP-2, rhBMP-7
By Application
Spinal Fusion, Trauma, Reconstructive Surgery, Oral-Maxillofacial, Others
By Companies
Medtronic, Cellumed, Stryker, Sigma Aldrich, ProSpec, Ember therapeutics, R&D Systems, Thermo Fischer, Medtronic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Bone Morphogenetic Proteins Market Report Segments:
The global Bone Morphogenetic Proteins market is segmented on the basis of:
Types
rhBMP-2, rhBMP-7
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Spinal Fusion, Trauma, Reconstructive Surgery, Oral-Maxillofacial, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Cellumed
- Stryker
- Sigma Aldrich
- ProSpec
- Ember therapeutics
- R&D Systems
- Thermo Fischer
- Medtronic
Highlights of The Bone Morphogenetic Proteins Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- rhBMP-2
- rhBMP-7
- By Application:
- Spinal Fusion
- Trauma
- Reconstructive Surgery
- Oral-Maxillofacial
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bone Morphogenetic Proteins Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bone morphogenetic proteins (BMPs) are a family of proteins that play an important role in the development and growth of bones. BMPs work by signaling cells to change their behavior, which can lead to the formation of new bone tissue.
Some of the major companies in the bone morphogenetic proteins market are Medtronic, Cellumed, Stryker, Sigma Aldrich, ProSpec, Ember therapeutics, R&D Systems, Thermo Fischer, Medtronic.
The bone morphogenetic proteins market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bone Morphogenetic Proteins Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bone Morphogenetic Proteins Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bone Morphogenetic Proteins Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bone Morphogenetic Proteins Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bone Morphogenetic Proteins Market Size & Forecast, 2020-2028
4.5.1 Bone Morphogenetic Proteins Market Size and Y-o-Y Growth
4.5.2 Bone Morphogenetic Proteins Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 rhBMP-2
5.2.2 rhBMP-7
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Spinal Fusion
6.2.2 Trauma
6.2.3 Reconstructive Surgery
6.2.4 Oral-Maxillofacial
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bone Morphogenetic Proteins Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bone Morphogenetic Proteins Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 rhBMP-2
9.6.2 rhBMP-7
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Spinal Fusion
9.10.2 Trauma
9.10.3 Reconstructive Surgery
9.10.4 Oral-Maxillofacial
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 rhBMP-2
10.6.2 rhBMP-7
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Spinal Fusion
10.10.2 Trauma
10.10.3 Reconstructive Surgery
10.10.4 Oral-Maxillofacial
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 rhBMP-2
11.6.2 rhBMP-7
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Spinal Fusion
11.10.2 Trauma
11.10.3 Reconstructive Surgery
11.10.4 Oral-Maxillofacial
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 rhBMP-2
12.6.2 rhBMP-7
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Spinal Fusion
12.10.2 Trauma
12.10.3 Reconstructive Surgery
12.10.4 Oral-Maxillofacial
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 rhBMP-2
13.6.2 rhBMP-7
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Spinal Fusion
13.10.2 Trauma
13.10.3 Reconstructive Surgery
13.10.4 Oral-Maxillofacial
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bone Morphogenetic Proteins Market: Competitive Dashboard
14.2 Global Bone Morphogenetic Proteins Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Cellumed
14.3.3 Stryker
14.3.4 Sigma Aldrich
14.3.5 ProSpec
14.3.6 Ember therapeutics
14.3.7 R&D Systems
14.3.8 Thermo Fischer
14.3.9 Medtronic
